Find verified Letermovir API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Letermovir for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Letermovir API.
Alternate Names: Prevymis, Letermovirum
CAS No: 917389-32-3
PubChem CID: 45138674
Mol Formula: C29H28F4N4O4
Mol Weight: 572.5 g/mol
IUPAC Name: 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetic acid
API Description: Letermovir recieved approval from the FDA on November 8th, 2017 for use in prophylaxis of cytomegalovirus (CMV) infection in allogeneic hematopoietic stem cell transplant patients. It is the first of a new class of CMV anti-infectives called DNA terminase complex inhibitors. Letermovir has recieved both priority and orphan drug status from the FDA. It is currently marketed under the brand name Prevymis.
